# AppliedXL > AppliedXL builds intelligence infrastructure for the information industry. Its editorial algorithms turn the public record — clinical trial registries, regulatory filings, and other institutional sources — into source-linked signals, indicators, forecasts, and market resolution, delivered before events become news. AppliedXL was founded by computational journalists. Its first vertical is biopharma: machine-scale monitoring of clinical trials and regulatory activity, probability-of-success forecasts, and authoritative event resolution for prediction markets. Contact: support@appliedxl.com. Sitemaps: [Site](https://www.appliedxl.com/sitemap-index.xml) · [News index](https://appliedxl.com/news/sitemap-index.xml) · [News](https://appliedxl.com/news/news-sitemap.xml) ## Platform - [The Event Layer](https://www.appliedxl.com/): AppliedXL detects material changes in authoritative records and delivers verified intelligence to institutions and information providers. - [Platform — The Event Engine](https://www.appliedxl.com/platform): The Event Engine monitors authoritative records, detects material changes, verifies evidence and delivers event intelligence for news, analytics, forecasts, indexes and resolution. - [AXL Atlas — Map domain expertise into a repeatable event system](https://www.appliedxl.com/platform/atlas): AXL Atlas defines the sources, event types, relationships, materiality rules and evidence required to detect change consistently. - [Pharma Event Atlas](https://www.appliedxl.com/platform/atlas-in-action): A live view of the sources, event definitions, relationships and evidence requirements behind AppliedXL’s clinical and regulatory coverage. - [Every product, in your infrastructure](https://www.appliedxl.com/platform/delivery): Verified event intelligence ships through the systems you already run, point-in-time correct, source-linked and resolved to your identifiers. - [Trust is the product](https://www.appliedxl.com/platform/trust-chain): Every event carries source-linked evidence, a timestamp, entity mapping, classification and correction history, creating a visible chain from authoritative record to customer output. ## Products - [Event probability, learned from history.](https://www.appliedxl.com/forecasts): Forecasts estimates outcome probability and timing from point-in-time event histories, updating as new verified events change the record. - [Verified event histories, turned into analytics and indexes.](https://www.appliedxl.com/indicators): Indicators turns recurring events and retained history into measures, benchmarks, rankings and index inputs. - [Outcomes resolved against the official record.](https://www.appliedxl.com/resolution): Resolution monitors predefined events, verifies the evidence, and produces documented outcome analysis for exchange settlement. - [Material change, detected and verified in real time.](https://www.appliedxl.com/signals): Signals continuously monitors authoritative records and turns material events into source-linked alerts, briefings and news. ## Solutions - [Built for institutions and information providers](https://www.appliedxl.com/solutions): Use verified event intelligence to power news, analytics, forecasts, indexes and resolution products. - [Build benchmarks from how companies and projects develop.](https://www.appliedxl.com/solutions/exchanges): Build benchmarks from how companies and projects develop. - [Event feeds for your terminal and data products.](https://www.appliedxl.com/solutions/financial-desktops): Deliver news, event histories and analytics through the workflows your customers already use. - [Turn the records on your beat into news and data products.](https://www.appliedxl.com/solutions/newsrooms): Use the same event records for reporting leads, subscriber trackers, briefings and licensed data feeds. - [More markets. Source-linked resolution.](https://www.appliedxl.com/solutions/prediction-markets): Support prediction market outcome analysis with predefined rules, designated sources and auditable evidence; exchanges retain settlement authority. - [Track commitments from disclosure to financial consequence.](https://www.appliedxl.com/solutions/ratings-risk): Power sector-wide screeners, real-time news and credit research with dated commitment records and supporting evidence. - [Extend your coverage with events your customers can use.](https://www.appliedxl.com/solutions/specialist-providers): Turn those developments into news, research updates and structured data your customers can use in their own workflows. ## Themes - [One Event Engine across regulated markets.](https://www.appliedxl.com/themes): Each new domain reuses the core engine and delivery infrastructure. Coverage expands through specialized sources, event definitions and materiality rules. - [Track when data-center plans become power demand.](https://www.appliedxl.com/themes/ai-infrastructure): Connect project announcements to utility commitments, revised delivery dates and operating evidence. Support news and demand research while distinguishing planned capacity from disclosed consumption. - [Track the projects and agreements behind new materials supply.](https://www.appliedxl.com/themes/critical-materials): Review how funding, permits and offtake agreements change a project’s production timetable. - [Track energy projects from commitments to operation.](https://www.appliedxl.com/themes/energy-transition): Review the permits, grid decisions and financing developments behind a project’s progress. - [Track how drugs, trials and regulatory decisions develop.](https://www.appliedxl.com/themes/human-health): Follow the drugs, trials and sponsors your team covers. Connect each development to its history and source evidence for news, research and analytics. - [Follow the official actions that change obligations and market access.](https://www.appliedxl.com/themes/systemic-risk): Track actions affecting your companies, suppliers and jurisdictions. Connect initial announcements to amendments, effective dates and outcomes for reporting, monitoring and research. ## Research - [Research and Insights](https://www.appliedxl.com/research): Research advances the methods behind event detection and outcome prediction. We study how public records reveal events and how institutions use the resulting intelligence. - [AppliedXL and Bain: A New Pharma Operating Discipline](https://www.appliedxl.com/research/appliedxl-bain-operating-discipline): A combined framework that pairs real-time AI monitoring with strategic analysis, turning clinical-trial execution into a measurable operational advantage. - [AppliedXL Partners with Bloomberg](https://www.appliedxl.com/research/appliedxl-bloomberg-partnership): Bloomberg Terminal users now have access to AppliedXL's AI-generated coverage of clinical trials, built to surface catalyst events in the pharmaceutical pipeline. - [AppliedXL and Kalshi Partner on Biopharma Prediction Markets](https://www.appliedxl.com/research/appliedxl-kalshi-partnership): The pilot covers selected contracts tied to clinical trial outcomes and FDA decisions, using predefined criteria and evidence from the public record. - [Vertical AI vs. General AI: Biopharma Benchmark](https://www.appliedxl.com/research/appliedxl-vs-claude-chatgpt-perplexity-biopharma): A head-to-head benchmark of AppliedXL against Claude, ChatGPT, and Perplexity on real biopharma research tasks, measuring depth, domain reasoning, and accuracy. - [Biopharma's Public Probability](https://www.appliedxl.com/research/biopharma-public-probability): A new report from Kalshi and AppliedXL on the state and future of prediction markets in drug development — and what happens when expectations become public prices. - [Biopharma's Public Probability — AppliedXL & Kalshi](https://www.appliedxl.com/research/biopharma-public-probability-report): The State and Future of Prediction Markets in Drug Development. The full web edition of the joint AppliedXL and Kalshi report on biopharma prediction markets. - [Clinical Trial Data as Alpha: Biotech Quant Model](https://www.appliedxl.com/research/clinical-trial-alpha-quant-model): AppliedXL built a biotech quant investing model on point-in-time clinical trial data enriched with SEC filings, press releases, and AI agents. - [State-of-the-Art Clinical Trial Prediction](https://www.appliedxl.com/research/clinical-trial-prediction): Clinical trials don't just succeed or fail. They pass through five sequential checkpoints, and failure can concentrate at any one of them. - [FDA Drug Repurposing: 5 Drugs Without a Champion](https://www.appliedxl.com/research/fda-drug-repurposing-intelligence): The FDA opened a public docket requesting input on drug repurposing opportunities where commercial incentives are insufficient to drive new applications. - [The Hidden Signals That Decide Drug Success or Failure](https://www.appliedxl.com/research/hidden-signals-drug-success-failure): AppliedXL decodes subtle shifts in clinical trials flagging risks and opportunities before they hit the news cycle. - [From Public Record to Resolution](https://www.appliedxl.com/research/how-a-market-resolves): AppliedXL identifies commitments in public records, tracks the events attached to them, and establishes outcomes with evidence you can review. The resulting record supports prediction-market resolution and analysis of financial commitments. - [Original Intelligence](https://www.appliedxl.com/research/original-intelligence): For two centuries, information companies were paid for two things at once: originating what is true, and delivering it. AI has split the bundle and priced the halves at opposite extremes. Delivery is becoming a commodity. Origination is becoming the whole business. - [Prediction Model: Six Clinical Trial Case Studies](https://www.appliedxl.com/research/prediction-model-six-clinical-trial-case-studies): Six clinical trials tracked from first filing to outcome. - [The Readout Gap](https://www.appliedxl.com/research/readout-gap): A study of 681 clinical trials found the dates companies give for results are usually missed — and when they slip, far more often late than early. - [Seeing Risk Before It Becomes News](https://www.appliedxl.com/research/seeing-risk-before-news): Execution failures rarely appear suddenly. They build quietly inside clinical programs until they spill into earnings calls, regulatory filings, or headlines. - [Spillover Risk and Readthrough Alpha](https://www.appliedxl.com/research/spillover-risk-readthrough-alpha): Registry anomalies precede press releases by 48-72 hours. - [Systematic Trading Strategies in Biotech](https://www.appliedxl.com/research/systematic-trading-strategies-biotech): Exploratory research on using structured clinical trial event data for alpha generation: early instability detection, mechanistic readthrough, and more. - [Who Will Monetize Truth? A Thesis For the Future of Information](https://www.appliedxl.com/research/who-will-monetize-truth): A thesis for the future of the information business: the news industry is being repriced around companies that sell awareness versus those that sell action. ## Company - [AppliedXL builds the Event Layer for authoritative records](https://www.appliedxl.com/about): AppliedXL detects material changes in continuously changing records and turns them into verified event intelligence for institutions and information providers. - [The Science of First](https://www.appliedxl.com/book): How changes in public records reveal emerging events. Francesco Marconi shows how early signals in data, behavior, and narrative reveal the shifts that matter before they become news. - [Put the Event Layer to work in your domain.](https://www.appliedxl.com/contact): Tell us the records, events and decisions that matter to your organization. We’ll scope how the Event Engine can detect material changes and deliver verified intelligence into your product or workflow. ## Legal - [Privacy Policy](https://www.appliedxl.com/privacy): How Applied X Lab, Inc. collects, uses, and shares personal information through our website, platform, and related services. - [Terms of Use](https://www.appliedxl.com/terms): The Terms of Use governing access to AppliedXL.com and AppliedXL’s website content, operated by Applied X Lab, Inc. ## Other - [Intelligence Strategy Assessment](https://www.appliedxl.com/assessment): Take the three-minute assessment. We’ll identify the authoritative sources, material events and product opportunities in your domain and turn them into a customized executive playbook. - [Event Atlas topology](https://www.appliedxl.com/axl-core-topology) - [AppliedXL Biotech — The biotech record, before it's news.](https://www.appliedxl.com/biotech): AppliedXL monitors clinical and regulatory records for material events, preserves point-in-time history and turns those events into news, analytics and forecasts. - [AI Editorial Policy](https://www.appliedxl.com/editorial-policy): AppliedXL's AI Editorial Policy: the standards that govern our editorial systems — curated primary sources, traceable provenance, algorithmic accuracy checks, human oversight, and editorial independence. - [FAQ — Biopharma Prediction Markets](https://www.appliedxl.com/faq-resolution-event-contracts): Frequently asked questions about the Kalshi–AppliedXL partnership, biopharma prediction markets, how resolution works, and the safeguards behind the markets. - [Going Live — See results in days. Fully launched in weeks.](https://www.appliedxl.com/going-live): AppliedXL scopes a domain, maps its sources and events, validates Event Engine output and delivers a working feed into your environment. - [Media & Partnerships](https://www.appliedxl.com/media): For press inquiries, partnerships and speaking requests, contact the AppliedXL team directly. - [Site Map](https://www.appliedxl.com/sitemap): A complete index of every page on appliedxl.com — platform, products, solutions, themes, research, and company pages. ## Live Exploration - [Biopharma News](https://appliedxl.com/news): The wire — AI-generated clinical trial and regulatory coverage, in production. - [Pharma Forecast Platform](https://appliedxl.ai/): Clinical trial probability of success and regulatory approval forecasts, live.